{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013108","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.254615+00:00","generated_at":"2026-05-17T06:44:25.235922+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Processa shareholders approve 10x increase in authorized shares, reverse split up to 1:50","bullets":["Approved increase of authorized common shares from 100M to 1B (13.7M for, 3.0M against).","Approved reverse stock split at ratio 1:2 to 1:50, effective by Dec 31, 2026 (13.9M for).","Approved amendment to 2019 Omnibus Incentive Plan to increase shares available (13.6M for).","Adjournment proposal approved but not needed due to sufficient votes on substantive proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013108","json":"https://secwatch.observer/filing/0001493152-25-013108.json","markdown":"https://secwatch.observer/filing/0001493152-25-013108.md","text":"https://secwatch.observer/filing/0001493152-25-013108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225013108/0001493152-25-013108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225013108/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:44:25.235922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}